Tigermed (03347) has announced that on November 18, 2026, it spent 45.672 million yuan to repurchase 1.0046 million A-shares.
The company disclosed the share buyback in a filing, confirming the transaction value and volume of A-shares acquired on that date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments